Demirhindi, H. Et Al. 2022. Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study. VACCINES , vol.10, no.5 .

Demirhindi, H., Mete, B., Tanır, F., Kara, E., Kibar, F., Çetiner, S., ... Candevir, A.(2022). Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study. VACCINES , vol.10, no.5.

Demirhindi, HAKAN Et Al. "Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study," VACCINES , vol.10, no.5, 2022

Demirhindi, HAKAN Et Al. "Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study." VACCINES , vol.10, no.5, 2022

Demirhindi, H. Et Al. (2022) . "Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study." VACCINES , vol.10, no.5.

@article{article, author={HAKAN DEMİRHİNDİ Et Al. }, title={Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study}, journal={VACCINES}, year=2022}